Skip to main content
. 2017 May 31;9:44. doi: 10.1186/s13098-017-0242-0

Fig. 2.

Fig. 2

Change in body weight after treatment of obese individuals with four liraglutide doses (1.2, 1.8, 2.4, or 3.0 mg) or to placebo administered once a day subcutaneously, or orlistat (120 mg) three times a day orally. Data are mean (95% CI) for the ITT population with the last observation carried forward (LOCF)

Adapted from Astrup et al. [35]